David Odde
University of Minnesota-Twin Cities
H-index: 54
North America-United States
Top articles of David Odde
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Favorable Antiviral Effect of Metformin on Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of Coronavirus Disease 2019 | Clinical Infectious Diseases | Carolyn T Bramante Kenneth B Beckman Tanvi Mehta Amy B Karger David J Odde | 2024/5/1 |
Abstract C046: Enhancing T cell infiltration and migration in the pancreatic tumor microenvironment | Cancer Research | Hongrong Zhang Guhan Qian Zhongming Chen Branden Moriarity Ingunn Stromnes | 2024/1/16 |
The OTX2 Gene Induces Tumor Growth and Triggers Leptomeningeal Metastasis by Regulating the mTORC2 Signaling Pathway in Group 3 Medulloblastomas | International Journal of Molecular Sciences | Elisabet Ampudia-Mesias Charles S Cameron Eunjae Yoo Marcus Kelly Sarah M Anderson | 2024/4/17 |
Abstract B003: The OTX2 gene induces tumor growth and triggers leptomeningeal metastasis by regulating the mTOR signaling pathway in medulloblastomas | Cancer Research | Elisabet Ampudia Mesias Charles Scott Cameron Sarah Anderson Juan E Abrahante Lloréns Christopher L Moertel | 2024/3/4 |
Glioblastoma cells use an integrin-and CD44-mediated motor-clutch mode of migration in brain tissue | Cellular and Molecular Bioengineering | Sarah M Anderson Marcus Kelly David J Odde | 2024/3/4 |
Biophysical modeling defines an optimal hybrid amoeboid-mesenchymal phenotype for T cell migration | Biophysical Journal | Roberto Alonso Matilla Paolo P Provenzano David J Odde | 2024/2/8 |
Photoresponsive Hydrogels for Studying Mechanotransduction of Cells | Keun-Young Park David J Odde Mark D Distefano | 2023/1/1 | |
Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial | The Lancet Infectious Diseases | Carolyn T Bramante John B Buse David M Liebovitz Jacinda M Nicklas Michael A Puskarich | 2023/6/8 |
Optimization of CD200 checkpoint immunotherapy for treating glioblastoma | Biophysical journal | Nikolaos Memmos Jaciah Rashid Elisabet Ampudia-Mesias Michael Olin David J Odde | 2023/2/10 |
RAD-TGTs: high-throughput measurement of cellular mechanotype via rupture and delivery of DNA tension probes | Nature communications | Matthew R Pawlak Adam T Smiley Maria Paz Ramirez Marcus D Kelly Ghaidan A Shamsan | 2023/4/28 |
Glioblastoma cell invasion: Go? Grow? Yes | David J Odde | 2023/12/1 | |
Optimal cell traction forces in a generalized motor-clutch model | Biophysical journal | Roberto Alonso-Matilla Paolo P Provenzano David J Odde | 2023/8/22 |
Impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination and booster on coronavirus disease 2019 (COVID-19) symptom severity over time in the COVID … | Clinical Infectious Diseases | David R Boulware Thomas A Murray Jennifer L Proper Christopher J Tignanelli John B Buse | 2023/2/1 |
68 Metformin prevents the diagnosis of Long Covid in phase 3 trial of early treatment. | Journal of Clinical and Translational Science | Carolyn Bramante Esteban Wirtz John Buse David Boulware Jacinda Nicklas | 2023/4 |
Radiation therapy and myeloid-derived suppressor cells: breaking down their cancerous partnership | Kyra M Boorsma Bergerud Matthew Berkseth Drew M Pardoll Sudipto Ganguly Lawrence R Kleinberg | 2023/11/30 | |
Identifying the Mechanism of Glioblastoma Cell Migration in Mouse Brain Slices | Sarah M Anderson David J Odde | 2023/8/1 | |
The Microtubule Severing Protein UNC-45A Counteracts the Microtubule Straightening Effects of Taxol | bioRxiv | Asumi Hoshino Valentino Clemente Mihir Shetty Brian Castle David Odde | 2023 |
Outpatient treatment of COVID-19 and the development of long COVID Over 10 Months: A multi-center, quadruple-blind, parallel group randomized phase 3 trial | Carolyn Bramante John B Buse David Liebovitz Jacinda Nicklas Michael Puskarich | 2023/3/6 | |
Biophysical modeling identifies an optimal hybrid amoeboid-mesenchymal phenotype for maximal T cell migration speeds | bioRxiv | Roberto Alonso Matilla Paolo Provenzano David J Odde | 2023 |
Metformin Reduced SARS-CoV-2 Viral Load in a Phase 3 Randomized Clinical Trial | Topics in Antiviral Medicine | DR Boulware C Bramante M Pullen J Buse D Odde | 2023 |
Co-Authors
